Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Search

Astellas Pharma Inc.

Japan
  • About
    • President and CEO’s Message
    • Philosophy
      • Charter of Corporate Conduct
    • Vision & Strategy
    • Corporate Governance
      • Group Code of Conduct
    • Risk Management
    • Corporate Information
      • Subsidiaries & Locations
      • Management
    • History
    • Board of Directors
    • Top Management
    • Main Products
    • Policies & Position Statements
    • Ethics & Compliance
    • Medical Care & Pharmaceutical Information
    Recommended
    Strategic Plan 2018
    Read More
  • Science
    • Focus Area Approach
    • Astellas Biomedical Innovation Hub
    • Rx+®
    • Data, Informatics and Analytics
    • Major Pipeline
    • Clinical Trials
    Recommended
    Focus Area Approach

    The Focus Area, where we put our efforts, consists of combinations of three components: 1) biology, 2) modality/technology, 3) diseases.

    Read More
  • Partnering
    • Areas of Interest
    • Why Partner with Astellas
    • Primary Focus
      • Blindness & Regeneration
      • Mitochondria Biology
      • Genetic Regulation
      • Immuno-Oncology
    • Biology, Modality/Technology of Interest
      • Innate Immunity (Innate Lymphoid Cells)
      • Autophagy
      • Protein Knockdown
    • Primary Focus Candidates
    • Cell Therapy
    • Rx+® - New Healthcare Solutions Beyond Medicine
      • Chronic Disease Progression Prevention
      • Motor Function Support/Replacement
      • Digital × Neuroscience
      • Patient w/o Effective Medicines
      • Patient Outcome Maximization via Precise Surgery/Diagnosis
      • Sensory Function Support/Replacement
    • Partnering Teams
    • Get in Touch
    • For Academics
    Recommended
    Areas of Interest

    Astellas monitors Focus Areas from biology perspectives, modality/technology, and disease to identify promising areas for investment. 

    Read More
  • Responsibility
    • Our Commitment
    • Our CSR-Based Management
      • Materiality in CSR Activities
      • SDGs
      • ISO26000 and CSR-Based Management
      • United Nations Global Compact
      • 30% Club
    • Access to Health
      • Research Activities on Tuberculosis and Malaria
      • Research Activities on NTDs
      • Development of Pediatric Formulation for Schistosomiasis
      • GHIT Fund
      • Access Accelerated
      • Action on Fistula
    • Stakeholder Communications
      • Peer Support Training Program (in Japan)
      • Communication with Patients (in U.S.)
      • Communication with the World Anti-Doping Agency (WADA)
      • Local Community Dialogue
    • Five Fields of CSR-Based Management
      • Five Fields of CSR-Based Management Diagram
    • Business Activities
      • Responsible Business Activities
      • With our Business Partners
        • Basic policy for procurement activities involving suppliers
      • Modern Slavery Act 2015
      • Individual HCP Funding Decision
    • Society
      • Priority Areas of Astellas Domestic Social Contribution Activities
      • 1st priority
      • 2nd priority
      • 3rd priority
        • Changing Tomorrow Day
        • Flying Star Fund (Japan)
        • Donation of wheelchair vans in Japan
        • Donation of Ambulances in Japan
        • Disaster Relief Activities
      • Astellas Foundation
    • Environment
      • Definition of terms
      • EHS Management
        • Status of obtaining ISO Certification
        • Astellas Environment, Health & Safety Guidelines
      • Environment Initiatives
      • Climate Change Mitigation Measures
      • Breakdown of Energy Consumption
      • Sustainable Biodiversity Initiatives
        • Biodiversity and Astellas An Enlarged Version
        • The Biodiversity Burden Index and Revenue
      • Initiatives for Resource Recycling
      • Initiatives for Preventing Pollution
        • Further information on PRTR system
      • Environmental Impact of Products and Countermeasures
      • Environmental Accounting
        • Environment-related Investments and Expenses
      • Reporting coverage, methods, etc.
      • EHS Report
      • Independent Assurance Report
    • EMPLOYEES
      • HR Vision
      • Providing Opportunities for Employees to Succeed Globally
      • Diversity Management
      • Promoting Health Management
      • Occupational Health & Safety
      • Respect for Human Rights
      • Data
        • Major Programs (Japan)
        • Major Data (Japan)
    • Ethics & Compliance
    Recommended
    Access Accelerated

    Astellas participates in Access Accelerated. Access Accelerated is a first-of-its-kind, multi-stakeholder collaboration focused on improving...

    Read More
  • News
    • News
    • Stories
    Recommended
    Stories

    Stories about how Astellas members work to create innovation, as well as achieve business and sustainability strategic goals.

    Read More

Stakeholders menu

  • Investors
    • Strategic Plan 2018
    • Financial Information
      • Financial Highlights
      • Financial Data (Annual Data)
      • Financial Data (Quarterly Data)
      • Sales of Major Products
      • Revenue by Region
    • Annual Report
    • IR Library
      • Business Results
      • Overview of R&D Pipeline
      • IR Meetings
      • Consolidated Financial Statements and Footnotes
      • Corporate Governance Materials
    • IR Calendar
    • Stock & Rating Information
      • Shareholders Meeting
      • Shareholder Return
      • Current Share Status
      • Chart
      • Ratings
    • Analyst Coverage
    • Cautionary Statement
  • Careers
  • Contact Us

Common header menu

  • IMPORTANT NOTICE
  • WORLDWIDE
  • 日本語
  • English
  1. Home
  2. Responsibility
Important Notice

This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site.

Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

I Agree
logo
Thank you for visiting the Astellas Pharma Inc. Website.
You will enter external sites beyond here.
(This link opens in a new window)
Cancel Click here to leave this site.

Corporate Responsibility

Our Commitment

Our Commitment

As a research and development-oriented global pharmaceutical company, we are always working to develop innovative new drugs, especially in areas where...

Read More

Access to Health

Advances continue to be made in technology and medicine that address unmet medical needs. However, there still remain barriers for many people who...

Read More

Our CSR-Based Management

CSR-Based Management

At Astellas, we recognize our Corporate Social Responsibility (CSR) as our responsibility for any...

Stakeholder Communications

Astellas believes that communication with stakeholders is crucial when considering how it will...

Five Fields of CSR-Based Management

Astellas has established five fields of CSR-based management: Business Activities, Employees...

Access Accelerated

Astellas participates in Access Accelerated. Access Accelerated is a first-of-its-kind, multi-stakeholder collaboration focused on improving Non-Communicable Disease (NCD) care. Involving 22 biopharmaceutical companies, the initiative works with partners such as World Bank Group and the Union for International Cancer Control to help overcome a variety of access barriers to NCD medicines in low-income and lower-middle income countries. Access Accelerated will support multi-stakeholder dialogue and begin on-the-ground work to improve NCD prevention, diagnosis and treatment.

Read More
Stories

Stories about how Astellas members work to create innovation, as well as achieve business and sustainability strategic goals.

Read More
Annual Report

We have published an annual report as an integrated report to enable deeper stakeholder understanding of Astellas’ efforts to continue to create value for Astellas held the following stakeholder dialogue with the aim of ascertaining expert opinions on selection of CSR core issues and medium-to long-term CSR activities that should be implemented.

Read More

Follow us on social media

Youtube Logo

Bottom footer menu

  • SITE MAP
  • PRIVACY POLICY
  • ACCESSIBILITY
  • TERMS OF USE
  • CONTACT US
  • DISASTER INFORMATION FOR EMPLOYEES
© Astellas Pharma Inc.